Matrix metalloproteinases in subjects with type 1 diabetes

BMC Clinical Pathology

Volumn 9, Issue 1, 2009, Pages

  Gharagozlian, Sedegheh ^a,b   Svennevig, Katja ^a   Bangstad, Hans Jacob ^c   Winberg, Jan Olof ^d   Kolset, Svein Olav ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b AKER UNIVERSITY HOSPITAL   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; SYNDECAN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARTICLE; BLOOD SAMPLING; CELL ULTRASTRUCTURE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; POLYACRYLAMIDE GEL ELECTROPHORESIS; RISK ASSESSMENT; WESTERN BLOTTING; ZYMOGRAPHY;

EID: 70349811339     PISSN: 14726890     EISSN: 14726890     Source Type: Journal    
DOI: 10.1186/1472-6890-9-7     Document Type: Article

References (15)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993 329 14 977 986 10.1056/NEJM199309303291401 8366922
2. Kidney function and glomerulopathy over 8 years in young patients with Type I (insulin-dependent) diabetes mellitus and microalbuminuria. HJ Bangstad R Osterby S Rudberg A Hartmann K Brabrand KF Hanssen, Diabetologia 2002 45 2 253 261 10.1007/s00125-001-0744-y 11935157
3. Structural changes in renal arterioles in Type I diabetic patients. R Osterby A Hartmann HJ Bangstad, Diabetologia 2002 45 4 542 549 10.1007/s00125-002-0780-2 12032631
4. Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy. HJ Bangstad R Osterby K Dahl-Jorgensen KJ Berg A Hartmann KF Hanssen, Diabetologia 1994 37 5 483 490 10.1007/s001250050136 8056186
5. Reversal of lesions of diabetic nephropathy after pancreas transplantation. P Fioretto MW Steffes DE Sutherland FC Goetz M Mauer, N Engl J Med 1998 339 2 69 75 10.1056/NEJM199807093390202 9654536 (Pubitemid 28304880)
6. Increased syndecan-1 in serum is related to early nephropathy in type I diabetes mellitus patients. K Svennevig SO Kolset HJ Bangstad, Diabetologia 2006 49 9 2214 2216 10.1007/s00125-006-0330-4 16832664
7. Matrix metalloproteinases in renal development and disease. O Lenz SJ Elliot WG Stetler-Stevenson, J Am Soc Nephrol 2000 11 3 574 581 10703682
8. Basement membrane synthesis and degradation. PN Furness, J Pathol 1997 183 1 1 3 10.1002/(SICI)1096-9896(199709)183:1<1::AID-PATH10963.0.CO;2-N 9370939
9. High glucose and Nepsilon-(carboxymethyl) lysine bovine serum albumin modulate release of matrix metalloproteinases in cultured human endothelial cells. S Gharagozlian T Henriksen SO Kolset, Eur J Nutr 2006 45 5 283 290 10.1007/s00394-006-0597-8 16705353
10. Effect of hyperglycemic condition on proteoglycan secretion in cultured human endothelial cells. S Gharagozlian J Borrebaek T Henriksen TK Omsland H Shegarfi SO Kolset, Eur J Nutr 2006 45 7 369 375 10.1007/s00394-006-0608-9 16810465
11. Matrix Metalloproteinase-2 Dysregulation in Type I Diabetes. KM Thrailkill RC Bunn CS Moreau GE Cockrell PM Simpson HN Coleman JP Frindik SF Kemp JL Fowlkes, Diabetes Care 2007 30 9 2321 2326 10.2337/dc07-0162 17563344
12. Elevated circulating levels of matrix metalloproteinase-9 in type I diabetic patients with and without retinopathy. S Jacqueminet O Ben Abdesselam MJ Chapman N Nicolay MJ Foglietti A Grimaldi JL Beaudeux, Clin Chim Acta 2006 367 1-2 103 107 10.1016/j.cca.2005.11.029 16426593
13. Increased circulatory MMP-2 and MMP-9 levels and activities in patients with type I diabetes mellitus. MY Shiau ST Tsai KJ Tsai ML Haung YT Hsu YH Chang, Mt Sinai J Med 2006 73 7 1024 1028 17195891
14. Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type I diabetes mellitus. G Derosa MA Avanzini D Geroldi R Fogari R Lorini A De Silvestri C Tinelli G Rondini G d'Annunzio, Diabetes Res Clin Pract 2005 70 2 119 125 10.1016/j.diabres.2005.03.020 16188574
15. Peripheral blood level alterations of TIMP-1, MMP-2 and MMP-9 in patients with type I diabetes. PR Maxwell PM Timms S Chandran D Gordon, Diabet Med 2001 18 10 777 780 10.1046/j.1464-5491.2001.00542.x 11678966